Lymna-DF-amide 3 is a gastropod RFamide-family peptide characterized from Lymnaea nervous tissue. Its C-terminal amide and aromatic motif favor interaction with neuromodulatory receptors. Researchers use it to examine circuit-specific control of feeding and locomotion. The peptide aids comparative analysis of RFamide signaling across invertebrate species.
CAT No: L14003
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.